01

02

03

04

05

Introduction

Mission Statement:

Tsinghua-Janssen Joint Research Center for Infectious Diseases

On November 3rd, 2010, Janssen Pharmaceutical and the Tsinghua University School of Medicine entered into a basic research agreement to establish the Tsinghua University School of Medicine – Janssen Pharmaceutical NV Joint Research Center for Infectious Diseases. The Center leverages Tsinghua’s research capabilities and innovations and Janssen’s strength and expertise in drug R&D to foster mutually beneficial research that allows both parties to better understand and combat infectious diseases that are highly prevalent in China, especially in the areas of HIV, tuberculosis, and viral hepatitis.

 

2010年11月3日,杨森制药公司与清华大学医学院达成基本研究协议,联合成立清华-杨森传染病联合研究中心。本着互惠互利、共同抗击传染病的理念,该研究中心充分利用清华大学的研发和创新能力以及杨森公司的药物研发优势,大力推进传染病领域的科学研究工作,在艾滋病、结核病、病毒性肝炎等切实关系人民身体健康和生活水平的几个重点领域展开深入研究,加速中国传染病研究的发展进程。

 

清华大学 • 清华大学医学院 • Janssen Infectious diseases and diagnosis • 强生中国研发中心